Exact Mass: 315.0638

Exact Mass Matches: 315.0638

Found 58 metabolites which its exact mass value is equals to given mass value 315.0638, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Oxfendazole

Oxfendazole

C15H13N3O3S (315.0678)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3672; ORIGINAL_PRECURSOR_SCAN_NO 3670 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3663; ORIGINAL_PRECURSOR_SCAN_NO 3660 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3677; ORIGINAL_PRECURSOR_SCAN_NO 3673 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3666; ORIGINAL_PRECURSOR_SCAN_NO 3662 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3739; ORIGINAL_PRECURSOR_SCAN_NO 3736 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3676; ORIGINAL_PRECURSOR_SCAN_NO 3674 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7569; ORIGINAL_PRECURSOR_SCAN_NO 7565 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7593; ORIGINAL_PRECURSOR_SCAN_NO 7591 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7621; ORIGINAL_PRECURSOR_SCAN_NO 7619 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7615; ORIGINAL_PRECURSOR_SCAN_NO 7613 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7596; ORIGINAL_PRECURSOR_SCAN_NO 7593 CONFIDENCE standard compound; INTERNAL_ID 438; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7629; ORIGINAL_PRECURSOR_SCAN_NO 7627 CONFIDENCE standard compound; INTERNAL_ID 1165 CONFIDENCE standard compound; INTERNAL_ID 1065

   

4-Hydroxyfenbendazole

4-Hydroxyfenbendazole

C15H13N3O3S (315.0678)


   

Oxfendazole

(5-(Phenylsulphinyl)-1H-benzimidazol-2-yl)carbamic acid methyl ester

C15H13N3O3S (315.0678)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent Anthelmintic, used in cattle, sheep and horse

   

4-Nitrophenyl beta-D-glucopyranosiduronic acid

3,4,5-trihydroxy-6-(4-nitrophenoxy)oxane-2-carboxylic acid

C12H13NO9 (315.059)


   

4-Hydroxyfenbendazole

methyl N-{5-[(4-hydroxyphenyl)sulfanyl]-3H-1,3-benzodiazol-2-yl}carbamate

C15H13N3O3S (315.0678)


   

Phosphonate analog

{5-[(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)methyl]oxolan-2-yl}phosphonate

C10H14N5O5P (315.0733)


   

TrkA Inhibitor

4-{[(2-hydroxy-1H-indol-3-yl)methylidene]amino}benzene-1-sulphonamide

C15H13N3O3S (315.0678)


   
   

Nicosulfuron-TP UCSN

Nicosulfuron-TP UCSN

C10H13N5O5S (315.0637)


CONFIDENCE standard compound; UCHEM_ID 4212

   
   

Sulfamide,N-(6-hydroxy-4,5,7-trimethyl-2-benzothiazolyl)-N,N-dimethyl-

Sulfamide,N-(6-hydroxy-4,5,7-trimethyl-2-benzothiazolyl)-N,N-dimethyl-

C12H17N3O3S2 (315.0711)


   

1-ETHANONE, 2-CHLORO-1-[2,5-DIMETHYL-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRROL-3-YL]-

1-ETHANONE, 2-CHLORO-1-[2,5-DIMETHYL-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRROL-3-YL]-

C15H13ClF3NO (315.0638)


   

3-CHLORO-3-(CYCLOPROPYLCARBAMOYL)-[1,1-BIPHENYL]-4-CARBOXYLIC ACID

3-CHLORO-3-(CYCLOPROPYLCARBAMOYL)-[1,1-BIPHENYL]-4-CARBOXYLIC ACID

C17H14ClNO3 (315.0662)


   

Valdecoxib Sulfonic Acid

Valdecoxib Sulfonic Acid

C16H13NO4S (315.0565)


   

[4-(pyridin-3-ylmethyl)morpholin-2-yl]methanamine

[4-(pyridin-3-ylmethyl)morpholin-2-yl]methanamine

C11H20Cl3N3O (315.0672)


   

tert-Butyl (S)-2-(4-bromo-1H-imidazol-2-yl)pyrrolidine-1-carboxylate

tert-Butyl (S)-2-(4-bromo-1H-imidazol-2-yl)pyrrolidine-1-carboxylate

C12H18BrN3O2 (315.0582)


   

7-Anilino-4-hydroxy-2-naphthalenesulfonic acid

7-Anilino-4-hydroxy-2-naphthalenesulfonic acid

C16H13NO4S (315.0565)


   

4-Nitrophenyl β-D-glucopyranosiduronic acid

4-Nitrophenyl beta-D-glucopyranosiduronic acid

C12H13NO9 (315.059)


   

3-[2-(4-Chlorophenoxy)phenyl]-1,5-dihydro-4-hydroxy-1-methyl-2H-pyrrol-2-one

3-[2-(4-Chlorophenoxy)phenyl]-1,5-dihydro-4-hydroxy-1-methyl-2H-pyrrol-2-one

C17H14ClNO3 (315.0662)


   

7-Anilino-1-naphthol-3-sulfonic Acid

7-Anilino-1-naphthol-3-sulfonic Acid

C16H13NO4S (315.0565)


   

2-CYANO-2-(3-ETHYL-4-OXO-5-((PHENYLAMINO)METHYLENE)THIAZOLIDIN-2-YLIDENE)ACETIC ACID

2-CYANO-2-(3-ETHYL-4-OXO-5-((PHENYLAMINO)METHYLENE)THIAZOLIDIN-2-YLIDENE)ACETIC ACID

C15H13N3O3S (315.0678)


   

N-(p-Toluenesulfonyl)indole-3-boronic acid

N-(p-Toluenesulfonyl)indole-3-boronic acid

C15H14BNO4S (315.0737)


   

1-(benzenesulfonyl)indole-2-carbohydrazide

1-(benzenesulfonyl)indole-2-carbohydrazide

C15H13N3O3S (315.0678)


   

5-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZO[1,3]DIOXOLE

5-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZO[1,3]DIOXOLE

C16H13NO4S (315.0565)


   

ETHYL 2-(2-[3-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-4-YL)ACETATE

ETHYL 2-(2-[3-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-4-YL)ACETATE

C14H12F3NO2S (315.0541)


   

3-[4-[(4-METHYLPHENYL)THIO]-3-NITROPHENYL]ACRYLIC ACID

3-[4-[(4-METHYLPHENYL)THIO]-3-NITROPHENYL]ACRYLIC ACID

C16H13NO4S (315.0565)


   

2-(2-CHLORO-ACETYLAMINO)-5,6,7,8-TETRAHYDRO-4H-CYCLOHEPTA[B]THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

2-(2-CHLORO-ACETYLAMINO)-5,6,7,8-TETRAHYDRO-4H-CYCLOHEPTA[B]THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

C14H18ClNO3S (315.0696)


   

3-[2-[(4-METHYLPHENYL)THIO]-5-NITROPHENYL]ACRYLIC ACID

3-[2-[(4-METHYLPHENYL)THIO]-5-NITROPHENYL]ACRYLIC ACID

C16H13NO4S (315.0565)


   

p-Nitrophenyl-beta-D-glucuronide

(2S,3S,4S,5R,6R)-3,4,5-Trihydroxy-6-(4-nitrophenoxy)tetrahydro-2H-pyran-2-carboxylic acid

C12H13NO9 (315.059)


   

Guanosine,7,8-dihydro-8-thioxo-

Guanosine,7,8-dihydro-8-thioxo-

C10H13N5O5S (315.0637)


   

[4-(pyridin-2-ylmethyl)morpholin-2-yl]methanamine

[4-(pyridin-2-ylmethyl)morpholin-2-yl]methanamine

C11H20Cl3N3O (315.0672)


   

{[4-Benzyl-5-(2-furyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid

{[4-Benzyl-5-(2-furyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid

C15H13N3O3S (315.0678)


   

3-amino-4-(4-chloro-3,5-dimethylphenoxy)benzotrifluoride

3-amino-4-(4-chloro-3,5-dimethylphenoxy)benzotrifluoride

C15H13ClF3NO (315.0638)


   
   

2-(2-CHLORO-ACETYLAMINO)-6-METHYL-4,5,6,7-TETRAHYDRO-BENZO[B]THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

2-(2-CHLORO-ACETYLAMINO)-6-METHYL-4,5,6,7-TETRAHYDRO-BENZO[B]THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

C14H18ClNO3S (315.0696)


   

3-(5-chloro-2-phenoxyphenyl)-1-methylpyrrolidine-2,4-dione

3-(5-chloro-2-phenoxyphenyl)-1-methylpyrrolidine-2,4-dione

C17H14ClNO3 (315.0662)


   

Ethyl 4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carboxylate

Ethyl 4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carboxylate

C14H12F3NO2S (315.0541)


   

AZD-4635

AZD-4635

C15H11ClFN5 (315.0687)


AZD4635 (HTL1071) is a potent, selective and orally active adenosine A2A receptor (A2AR) antagonist. AZD4635 binds to human A2AR with a Ki of 1.7 nM and shows >30-fold selectivity over other adenosine receptors[1].

   

N-((2-methyl-5-nitrophenyl)carbamothioyl)benzamide

N-((2-methyl-5-nitrophenyl)carbamothioyl)benzamide

C15H13N3O3S (315.0678)


   
   

2-(3-chloro-2-oxo-1,3-dihydroindol-4-yl)ethyl benzoate

2-(3-chloro-2-oxo-1,3-dihydroindol-4-yl)ethyl benzoate

C17H14ClNO3 (315.0662)


   

1-Methyl ethyl 2-chloro-5-[[[(1-methylethoxy)thiooxo]methyl]amino]-benzoate

1-Methyl ethyl 2-chloro-5-[[[(1-methylethoxy)thiooxo]methyl]amino]-benzoate

C14H18ClNO3S (315.0696)


   

2,5-Dideoxy-adenosine 3-monophosphate

2,5-Dideoxy-adenosine 3-monophosphate

C10H14N5O5P (315.0733)


   

3-[[Oxo(thiophen-2-yl)methyl]amino]-2-benzofurancarboxylic acid ethyl ester

3-[[Oxo(thiophen-2-yl)methyl]amino]-2-benzofurancarboxylic acid ethyl ester

C16H13NO4S (315.0565)


   

2,5-dihydroxybenzoic acid 5-O-beta-D-glucoside

2,5-dihydroxybenzoic acid 5-O-beta-D-glucoside

C13H15O9- (315.0716)


   

5-Hydroxy-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate

5-Hydroxy-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate

C13H15O9- (315.0716)


   

N-(1H-benzimidazol-2-yl)-2-methylsulfonylbenzamide

N-(1H-benzimidazol-2-yl)-2-methylsulfonylbenzamide

C15H13N3O3S (315.0678)


   

4-(4-chlorophenyl)-3-(2-phenylethyl)-1H-1,2,4-triazole-5-thione

4-(4-chlorophenyl)-3-(2-phenylethyl)-1H-1,2,4-triazole-5-thione

C16H14ClN3S (315.0597)


   

N-[5-[(4-methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide

N-[5-[(4-methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide

C15H13N3O3S (315.0678)


   

4-hydroxy-1-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydro-3-quinolinecarboxamide

4-hydroxy-1-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydro-3-quinolinecarboxamide

C15H13N3O3S (315.0678)


   

2-thiophen-2-ylethyl (Z)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enoate

2-thiophen-2-ylethyl (Z)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enoate

C16H13NO4S (315.0565)


   

2-Amino-3-[hydroxy-(2-hydroxy-3-propanoyloxypropoxy)phosphoryl]oxypropanoic acid

2-Amino-3-[hydroxy-(2-hydroxy-3-propanoyloxypropoxy)phosphoryl]oxypropanoic acid

C9H18NO9P (315.0719)


   

hydroxyfenbendazole

hydroxyfenbendazole

C15H13N3O3S (315.0678)


A member of the class of benzimidazoles that is fenbendazole in which the hydrogen at position 4 on the phenyl ring has been replaced by a hydroxy group.

   

4-nitrophenyl beta-D-glucuronide

4-nitrophenyl beta-D-glucuronide

C12H13NO9 (315.059)


A beta-D-glucosiduronic acid having a 4-nitrophenyl substituent at the anomeric position.

   
   

2-TEDC

2-TEDC

C16H13NO4S (315.0565)


2-TEDC is a potent inhibitor of 5-, 12-, and 15-lipoxygenase with IC50 values of 0.09 μM, 0.013 μM and 0.5 μM, respectively. 2-TEDC can be used for the research of atheroscrelosi[1].

   

1-[(2r,3r,4s,5r)-5-(1-amino-2-oxoethyl)-3,4-dihydroxyoxolan-2-yl]-4-hydroxy-2-oxopyrimidine-5-carboxylic acid

1-[(2r,3r,4s,5r)-5-(1-amino-2-oxoethyl)-3,4-dihydroxyoxolan-2-yl]-4-hydroxy-2-oxopyrimidine-5-carboxylic acid

C11H13N3O8 (315.0703)


   

4-bromo-n-(5-carbamimidamidopentyl)-1h-pyrrole-2-carboxamide

4-bromo-n-(5-carbamimidamidopentyl)-1h-pyrrole-2-carboxamide

C11H18BrN5O (315.0695)